{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:27:04Z","timestamp":1792801624669,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T00:00:00Z","timestamp":1488412800000},"content-version":"am","delay-in-days":305,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5R01ES010804"],"award-info":[{"award-number":["5R01ES010804"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5K24NS60991"],"award-info":[{"award-number":["5K24NS60991"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"DOD","doi-asserted-by":"publisher","award":["W81XWH-11-1-0150"],"award-info":[{"award-number":["W81XWH-11-1-0150"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.neuroscience.2016.02.035","type":"journal-article","created":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T04:00:33Z","timestamp":1456113633000},"page":"129-137","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Neuroprotection by caffeine in the MPTP model of parkinson\u2019s disease and its dependence on adenosine A2A receptors"],"prefix":"10.1016","volume":"322","author":[{"given":"K.","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.G.","family":"Di Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Orr\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-F.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Schwarzschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2016.02.035_b0005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pbb.2006.05.027","article-title":"Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats","volume":"84","author":"Aguiar","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2016.02.035_b9005","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00213-005-0173-6","article-title":"A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors","volume":"183","author":"Antoniou","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0010","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/aje\/kwh312","article-title":"Coffee consumption, gender, and Parkinson\u2019s disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen","volume":"160","author":"Ascherio","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson\u2019s disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0020","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1212\/01.WNL.0000046523.05125.87","article-title":"Caffeine, postmenopausal estrogen, and risk of Parkinson\u2019s disease","volume":"60","author":"Ascherio","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0025","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1128\/MCB.22.14.5100-5113.2002","article-title":"Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation","volume":"22","author":"Bajenaru","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0030","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.npp.1300630","article-title":"A crucial role for forebrain adenosine A2A receptors in amphetamine sensitization","volume":"30","author":"Bastia","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/physiolgenomics.00067.2002","article-title":"Of mice and models: improved animal models for biomedical research","volume":"11","author":"Bockamp","year":"2002","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0045","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/glia.10243","article-title":"Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes","volume":"43","author":"Brambilla","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neulet.2010.06.013","article-title":"Caffeine attenuates lipopolysaccharide-induced neuroinflammation","volume":"480","author":"Brothers","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0055","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1471-4159.2009.06425.x","article-title":"Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease","volume":"111","author":"Carta","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0060","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1523\/JNEUROSCI.19-21-09192.1999","article-title":"A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice","volume":"19","author":"Chen","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0065","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1073\/pnas.98.4.1970","article-title":"The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice","volume":"98","author":"Chen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0070","doi-asserted-by":"crossref","first-page":"RC143","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","article-title":"Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson\u2019s disease","volume":"21","author":"Chen","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.02.035_b9010","doi-asserted-by":"crossref","first-page":"36040","DOI":"10.1074\/jbc.M206830200","article-title":"8-(3-Chlorostyryl)caffeine may attenuate MPTP neurotoxicity through dual actions of monoamine oxidase inhibition and A2A receptor antagonism","volume":"277","author":"Chen","year":"2002","journal-title":"J Biol Chem."},{"key":"10.1016\/j.neuroscience.2016.02.035_b0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0197-0186(00)00034-6","article-title":"Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors","volume":"38","author":"Cunha","year":"2001","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0896-6273(02)00780-8","article-title":"Animal models of PD: pieces of the same puzzle?","volume":"35","author":"Dawson","year":"2002","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.neuroscience.2016.02.035_b0085","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1021\/cb5005383","article-title":"Uncovering caffeine\u2019s adenosine A2A receptor inverse agonism in experimental parkinsonism","volume":"9","author":"Fern\u00e1ndez-Due\u00f1as","year":"2014","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0090","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1471-4159.2007.05196.x","article-title":"An update on the mechanisms of the psychostimulant effects of caffeine","volume":"105","author":"Ferr\u00e9","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/(SICI)1098-1136(199610)18:2<152::AID-GLIA7>3.0.CO;2-2","article-title":"Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors","volume":"18","author":"Fiebich","year":"1996","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0100","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00018-003-3269-3","article-title":"Caffeine as a psychomotor stimulant: mechanism of action","volume":"61","author":"Fisone","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(99)00533-6","article-title":"Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A(2A) receptors","volume":"380","author":"Fredholm","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0110","first-page":"469","article-title":"Caffeine and ischemia\u2013effects on immediate early genes and adenosine receptors","volume":"71","author":"Fredholm","year":"1996","journal-title":"Adv Neurol"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0115","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0014-2999(82)90359-4","article-title":"Xanthine derivatives as adenosine receptor antagonists","volume":"81","author":"Fredholm","year":"1982","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0120","first-page":"9","article-title":"Glial cell participation in the degeneration of dopaminergic neurons in Parkinson\u2019s disease","volume":"80","author":"Hirsch","year":"1999","journal-title":"Adv Neurol"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0125","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.tips.2005.08.004","article-title":"Adenosine receptor signaling in the brain immune system","volume":"26","author":"Hasko","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0130","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.0022-3042.2001.00694.x","article-title":"Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson\u2019s disease","volume":"80","author":"Ikeda","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson\u2019s disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0140","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.parkreldis.2004.06.004","article-title":"Protective effect of caffeine against neurodegeneration in a model of Parkinson\u2019s disease in rat: behavioral and histochemical evidence","volume":"10","author":"Joghataie","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0145","unstructured":"Kachroo A, Prasad K, Irizarry MC, Richfield EK, Schwarzschild MA (2007), Caffeine protects against combined paraquat and maneb-induced neurotoxicity of dopaminergic nigral neurons. Program #265.20.2007 Society for Neuroscience Annual Meeting; San Diego, CA. 2007."},{"key":"10.1016\/j.neuroscience.2016.02.035_b0150","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1460-9568.2003.02747.x","article-title":"Enabling role of adenosine A1 receptors in adenosine A2A receptor-mediated striatal expression of c-fos","volume":"18","author":"Karcz-Kubicha","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0155","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00213-008-1319-0","article-title":"The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat","volume":"201","author":"Kelsey","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.ne.11.030188.000501","article-title":"MPTP toxicity: implication for research in Parkinson\u2019s disease","volume":"11","author":"Kopin","year":"1988","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0165","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0006-8993(84)90777-7","article-title":"Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl 1\u20131,2,3,6, tetrahydropyridine (MPTP) in the squirrel monkey","volume":"292","author":"Langston","year":"1984","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0170","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.neuroscience.2007.11.020","article-title":"Chronic but not acute treatment with caffeine attenuates traumatic brain injury in the mouse cortical impact model","volume":"151","author":"Li","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.expneurol.2008.09.012","article-title":"Genetic inactivation of adenosine A2A receptors attenuates acute traumatic brain injury in the mouse cortical impact model","volume":"215","author":"Li","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0180","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/aje\/kwr451","article-title":"Caffeine intake, smoking, and risk of Parkinson disease in men and women","volume":"175","author":"Liu","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0185","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/sj.bjp.0705692","article-title":"Binding of the prototypical adenosine A2A receptor agonist, CGS 21680, to the cerebral cortex of adenosine A1 and A2A receptor knockout mice","volume":"141","author":"Lopes","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0190","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/glia.22290","article-title":"Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes","volume":"60","author":"Matos","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0195","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.biopsych.2015.02.026","article-title":"Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia","volume":"78","author":"Matos","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JPD-2011-11023","article-title":"MPTP mouse models of Parkinson\u2019s disease: an update","volume":"1","author":"Meredith","year":"2011","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0205","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0165-0173(92)90012-B","article-title":"Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects","volume":"17","author":"Nehlig","year":"1992","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0210","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1254\/jphs.94.100","article-title":"ATP- and adenosine-mediated signaling in the central nervous system: adenosine stimulates glutamate release from astrocytes via A2a adenosine receptors","volume":"94","author":"Nishizaki","year":"2004","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0215","first-page":"404","article-title":"Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney","volume":"277","author":"Okusa","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0220","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.neuropharm.2012.11.029","article-title":"Psychostimulant pharmacological profile of paraxanthine the main metabolite of caffeine in humans","volume":"67","author":"Orr\u00fa","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0225","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/mds.25076","article-title":"Caffeine and risk of Parkinson\u2019s disease in a large cohort of men and women","volume":"27","author":"Palacios","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0230","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.neuropharm.2004.11.009","article-title":"KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse","volume":"48","author":"Pierri","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0235","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(95)00679-6","article-title":"Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats","volume":"287","author":"Popoli","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0240","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/NEN.0000000000000174","article-title":"Critical contribution of adenosine A2A receptors in bone marrow derived cells to white matter lesions induced bychronic cerebral hypoperfusion","volume":"74","author":"Ran","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0006-8993(87)90120-X","article-title":"Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra","volume":"403","author":"Ricaurte","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0250","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.neuroscience.2005.01.014","article-title":"Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat","volume":"132","author":"Rebola","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0255","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1471-4159.2011.07178.x","article-title":"Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction","volume":"117","author":"Rebola","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0260","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson disease","volume":"283","author":"Ross","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0265","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1471-4159.2005.03395.x","article-title":"Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia","volume":"95","author":"Saura","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0270","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.tins.2006.09.004","article-title":"Targeting adenosine A2A receptors in Parkinson\u2019s disease","volume":"29","author":"Schwarzschild","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2016.02.035_b9015","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1523\/JNEUROSCI.5255-07.2008","article-title":"A critical role of the adenosine A2A receptor in extrastriatal neurons in modulating psychomotor activity as revealed by opposite phenotypes of striatum and forebrain A2A receptor knock-outs","volume":"28","author":"Shen","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0275","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.expneurol.2012.01.022","article-title":"Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson\u2019s disease","volume":"234","author":"Sonsalla","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0280","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0896-6273(02)01067-X","article-title":"Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials","volume":"36","author":"Stevens","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0285","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1098-2299(199811\/12)45:3\/4<103::AID-DDR4>3.0.CO;2-W","article-title":"Role of A2A adenosine receptors in inflammation","volume":"45","author":"Sullivan","year":"1998","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0290","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1523\/JNEUROSCI.3008-05.2006","article-title":"Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease","volume":"26","author":"Xu","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0295","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.neuroscience.2010.02.020","article-title":"Neuroprotection by caffeine: Time course and role of its metabolites in the MPTP model of Parkinson Disease","volume":"167","author":"Xu","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0300","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(02)00069-1","article-title":"Caffeine\u2019s neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice","volume":"322","author":"Xu","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0305","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nm1103","article-title":"Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury","volume":"10","author":"Yu","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2016.02.035_b0310","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ana.21313","article-title":"Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms","volume":"63","author":"Yu","year":"2008","journal-title":"Ann Neurol"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452216001755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452216001755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T19:13:19Z","timestamp":1618686799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452216001755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":65,"alternative-id":["S0306452216001755"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2016.02.035","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}